Pharmafile Logo

Delivering change through better rare disease communications

February 28, 2020 |  

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.

Many innovative therapies are being launched in rare disease following years of research that has been driven by the emergence of new technology and regulatory incentives. This brings high levels of hope and expectation to the rare disease community. Consequently, it’s vital that biotechnology and pharmaceutical companies cut through the noise to bring real understanding and informed decision making about the next generation of orphan drugs. Doing this requires communications that encompass the right mix of tools, methodologies, channels and people.

EXPLORING THE CHALLENGES IN RARE DISEASE THROUGH BETTER COMMUNICATION STRATEGIES

OPEN Health recognises that there are multiple challenges in commercialising new therapies in rare disease and is leading future practice in communications by placing emphasis on a ‘patient first’ approach. This includes supporting Benjamin James’s recent analysis on what the future could look like for outcomes driven communications in this space. Benjamin is a trustee and patient advocate for DMD Pathfinders and has recently completed a Masters in Scientific Communications. This provides us with a valued perspective on how improvements can be made for the benefit of patients. A summary of his findings can be found here.

To read the full article click here.

Pink divider

Get in touch

For more information on our commitment to better outcomes in rare disease please contact:

Gavin Jones, Director of Rare Disease, OPEN Health

Gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Jeff Anderson joins OPEN Health as European Lead for OPEN VIE and Pharmerit

OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined...

OPEN Health Webinar – Succeeding with Star Wars Medicine

Summary of their recently published white paper on gene therapy followed by a Q&A session on 12th June 2020. Book now!

Yurie Oates, Account Director, OPEN Health gives us some Top tips from 5 years of account management on #MedCommsDay

WHAT IS ACCOUNT MANAGEMENT?Account/project managers support the day-to-day running of their account: they are the glue in a team who make sure projects are completed on brief, on time and...

A day in the life of an Associate Publications Director

Eleanor Raynsford, Associate Publications Director, OPEN Health gives us an insight into a day in the life of her role.

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19

Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time.

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

Ben Speller shares his thoughts on the value of disease specific congresses

OPEN Health use PR to support clinical trial recruitment

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers

OPEN Health attend day 2 of the ECRD2020 congress

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

OPEN Health continued support for My Name’5 Doddie

Charity fundraising for Motor Neuron Disease